FI972624A0 - 14alfa,17alfa-C2-sillan sisältäviä 19-norprogesteronijohdoksia - Google Patents

14alfa,17alfa-C2-sillan sisältäviä 19-norprogesteronijohdoksia

Info

Publication number
FI972624A0
FI972624A0 FI972624A FI972624A FI972624A0 FI 972624 A0 FI972624 A0 FI 972624A0 FI 972624 A FI972624 A FI 972624A FI 972624 A FI972624 A FI 972624A FI 972624 A0 FI972624 A0 FI 972624A0
Authority
FI
Finland
Prior art keywords
14alpha
17alpha
bridge
derivatives containing
norprogesterone derivatives
Prior art date
Application number
FI972624A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI972624A7 (fi
Inventor
Klaus Schoellkopf
Wolfgang Halfbrodt
Joachim Kuhnke
Wolfgang Schwede
Karl-Heinrich Fritzemeier
Rolf Krattenmacher
Hans-Peter Muhn
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI972624A7 publication Critical patent/FI972624A7/fi
Publication of FI972624A0 publication Critical patent/FI972624A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34Gestagens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FI972624A 1994-12-23 1997-06-18 14alfa,17alfa-C2-sillan sisältäviä 19-norprogesteronijohdoksia FI972624A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4447401A DE4447401A1 (de) 1994-12-23 1994-12-23 14,17-C¶2¶-überbrückte Steroide
PCT/EP1995/005107 WO1996020209A2 (de) 1994-12-23 1995-12-23 14α,17α-C2-ÜBERBRÜCKTE 19-NOR-PROGESTERONDERIVATE

Publications (2)

Publication Number Publication Date
FI972624A7 FI972624A7 (fi) 1997-06-18
FI972624A0 true FI972624A0 (fi) 1997-06-18

Family

ID=6537601

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972624A FI972624A0 (fi) 1994-12-23 1997-06-18 14alfa,17alfa-C2-sillan sisältäviä 19-norprogesteronijohdoksia

Country Status (33)

Country Link
US (3) US5827842A (cs)
EP (1) EP0799238B1 (cs)
JP (1) JPH10511379A (cs)
KR (1) KR100400621B1 (cs)
CN (1) CN1109689C (cs)
AR (1) AR002263A1 (cs)
AT (1) ATE193300T1 (cs)
AU (1) AU692346B2 (cs)
BG (1) BG63274B1 (cs)
CA (1) CA2208605C (cs)
CZ (1) CZ292696B6 (cs)
DE (2) DE4447401A1 (cs)
DK (1) DK0799238T3 (cs)
EE (1) EE03356B1 (cs)
ES (1) ES2151612T3 (cs)
FI (1) FI972624A0 (cs)
GR (1) GR3034261T3 (cs)
HU (1) HUP0600457A2 (cs)
IL (1) IL116504A (cs)
LT (1) LT4295B (cs)
LV (1) LV11954B (cs)
NO (1) NO310198B1 (cs)
NZ (1) NZ298770A (cs)
PL (1) PL182642B1 (cs)
PT (1) PT799238E (cs)
RO (1) RO119366B1 (cs)
RU (1) RU2169153C2 (cs)
SI (1) SI9520137A (cs)
SK (1) SK282281B6 (cs)
TW (1) TW333536B (cs)
UA (1) UA45382C2 (cs)
WO (1) WO1996020209A2 (cs)
ZA (1) ZA9510923B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4244997A (en) * 1996-09-03 1998-03-26 Chugai Seiyaku Kabushiki Kaisha Intermediates for the synthesis of vitamin d and steroid derivatives and processes for preparation thereof
DE19848305C1 (de) * 1998-10-14 2000-05-25 Schering Ag Verfahren zur Umsetzung von substituierten Propargylalkoholen in Gegenwart von sauren Ionenaustauschern und Zwischenprodukte des Verfahrens
DE19848303A1 (de) * 1998-10-14 2000-04-20 Schering Ag Kombination aus Gestagenen und Zuckern
EP1216699A1 (de) * 2000-12-21 2002-06-26 Schering Aktiengesellschaft Transdermalsystem enthaltend ein hochpotentes Gestagen
EP1652526B1 (en) * 2001-10-26 2009-01-14 N.V. Organon Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder
DE102007063503A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3628189A1 (de) 1986-08-20 1988-02-25 Schering Ag Oestrogen wirksame mittel und 14,17ss-ethano-14ss-estratriene
DE4326240A1 (de) 1993-08-02 1995-02-09 Schering Ag 15,15-Dialkyl-substituierte Derivate des Estradiols

Also Published As

Publication number Publication date
KR100400621B1 (ko) 2004-02-05
RU2169153C2 (ru) 2001-06-20
SI9520137A (sl) 1998-02-28
NO310198B1 (no) 2001-06-05
NO972927L (no) 1997-08-22
MX9704774A (es) 1997-10-31
DE59508403D1 (de) 2000-06-29
DE4447401A1 (de) 1996-07-04
ATE193300T1 (de) 2000-06-15
LV11954A (lv) 1998-01-20
CN1109689C (zh) 2003-05-28
PL320799A1 (en) 1997-10-27
CZ292696B6 (cs) 2003-11-12
PT799238E (pt) 2000-11-30
CZ195497A3 (cs) 1998-03-18
PL182642B1 (pl) 2002-02-28
FI972624A7 (fi) 1997-06-18
CA2208605C (en) 2008-07-15
NZ298770A (en) 1999-10-28
US5827842A (en) 1998-10-27
SK78897A3 (en) 1997-12-10
JPH10511379A (ja) 1998-11-04
CN1171115A (zh) 1998-01-21
WO1996020209A3 (de) 1996-09-06
SK282281B6 (sk) 2002-01-07
UA45382C2 (uk) 2002-04-15
LV11954B (lv) 1998-06-20
LT97106A (en) 1997-10-27
LT4295B (lt) 1998-02-25
DK0799238T3 (da) 2000-10-09
IL116504A0 (en) 1996-03-31
ZA9510923B (en) 1996-07-04
RO119366B1 (ro) 2004-08-30
WO1996020209A2 (de) 1996-07-04
HUP0600457A2 (en) 2006-08-28
IL116504A (en) 2001-11-25
ES2151612T3 (es) 2001-01-01
BG101554A (en) 1998-09-30
CA2208605A1 (en) 1996-07-04
US5973172A (en) 1999-10-26
EP0799238B1 (de) 2000-05-24
BG63274B1 (bg) 2001-08-31
EE03356B1 (et) 2001-02-15
AR002263A1 (es) 1998-03-11
NO972927D0 (no) 1997-06-23
US6147065A (en) 2000-11-14
AU692346B2 (en) 1998-06-04
EP0799238A2 (de) 1997-10-08
TW333536B (en) 1998-06-11
GR3034261T3 (en) 2000-12-29
AU4433896A (en) 1996-07-19

Similar Documents

Publication Publication Date Title
FI954829L (fi) Aroyylipiperidiinijohdannaiset
NO952854D0 (no) 1-arylpyrimidin-derivater
DE59508427D1 (de) 3-aryl-4-hydroxy-delta 3 -dihydrothiophenon-derivate
FI952424L (fi) 11,21-bisfenyyli-19-norpregaanijohdannaisia
EP0708091A3 (en) Indoloyl-guanidines derivatives
FI942119A0 (fi) Anordning i en gasblandare
DE69430587D1 (de) Pyrimidin-acyclonukleosid-derivate
FI971227L (fi) Pyramidinyylipyratsolijohdannaisia
FI960367A7 (fi) Uusia dialkoksipyridinyylibentsimidatsolijohdannaisia
BR9507892A (pt) Novos derivados de diamino-metilideno
FI964853L (fi) Deasetoksitaksolijohdannaiset
FI972624A0 (fi) 14alfa,17alfa-C2-sillan sisältäviä 19-norprogesteronijohdoksia
FI1592U1 (fi) Spruta, foeretraedesvis injektionsspruta
DE59509209D1 (de) Diphenyloxazolin-derivate
DE69510792D1 (de) Naphtochinonderivate
FI955026A7 (fi) Alkyyli-5-metyylisulfonyylibentsoyyliguanidiinijohdannaisia
BR9509877A (pt) Novos derivados de pirimidinilóxi-e piridimidinilamino- etilfenil-dioxolano
BR9509295A (pt) Escareador
DE69509037D1 (de) Entwicklungsanordnung
FI1516U1 (fi) Foerpackning foer i stapel anordnade smaoark
FI963122L (fi) Karbamoyylimetyyliureajohdannaiset
FI962961A0 (fi) Telebetalningssystem i realtid
KR960013117U (ko) 대다리
FI944648A0 (fi) Bromsmekanism foer fordon, saerskilt foer en cykel
FI945785A0 (fi) Pimpelspoe, fiskeredokap